Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
Same author

Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Sex differences in modifiable risk factors of dementia and their associations with cognition.

Biology of sex differences·2026
Same author

Diabetes, hyperglycemia, and ATN blood biomarkers in Hispanic/Latino populations: SOL-INCA study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Diabetes, hyperglycemia, and brain MRI biomarkers: results from SOL-INCA MRI study.

Nutrition & diabetes·2026
Same author

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Marcella A Barneclo1, Nancy E Ortega2,3, Iris J Broce-Diaz4

  • 1Alzheimer's Disease Cooperative Study, La Jolla, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

TOMM40-G基因组与阿尔茨海默病 (AD) 血生物标志物有关. 性和APOE4与TOMM40-G相互作用,影响AD风险生物标志物,表明复杂的性别特异性AD病理.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经科学是一个神经科学.
  • 遗传学 是一个遗传学.
  • 生物标志物研究 生物标志物研究

背景情况:

  • TOMM40基因,特别是SNP rs2075650 (TOMM40-G) 的G等位基因,是已知的阿尔茨海默病 (AD) 的风险变体.
  • 携带TOMM40-G的携带者可能因潜在的线粒体功能障碍,神经退行以及与年龄相关的疾病而面临AD风险增加.
  • 有限的研究存在于TOMM40-G与血AD生物标志物的关联,以及性别和APOE4.4的缓和作用.

研究的目的:

  • 调查TOMM40-G等位基因和在认知不受损的老年人中的血AD生物标志物之间的关联.
  • 检查潜在的性别差异和涉及TOMM40-G,性别和APOE4的相互作用,与AD生物标志物相关.
  • 探索TOMM40-G如何影响粉样β (Aβ),酸化 (ptau),GFAP和NfL的水平.

主要方法:

  • 分析了A4队列中的1,149名认知不受损的老年人的遗传和血生物标志物数据.
  • 调查的TOMM40-G (rs2075650) 载体与非载体之间的差异在Aβ42,Aβ42/40,ptau181,ptau217,GFAP和NfL.
  • 统计模型结合了性别和APOE4与TOMM40-G等位基因的相互作用条件,对年龄和教育进行控制.

主要成果:

  • 携带TOMM40-G的携带者表现出血生物标志物的改变,包括增加ptau217和减少Aβ42/40和Aβ42.
  • 在APOE4载体中,Aβ42/Aβ42/40较低,ptau181/ptau217.7较高.
  • 在ptau217,GFAP和Aβ42水平上观察到显著的性别差异. 性别和TOMM40-G之间的相互作用影响了NfL和Aβ42. 性别和APOE4的相互作用影响了Aβ42和Aβ42/40.

结论:

  • TOMM40-G风险等位基因与不同的血AD生物标志物概况相关.
  • APOE4和TOMM40-G可能与性别相互作用以调节AD生物标志物,突出复杂的性别特异性风险路径.
  • 需要进一步的研究,以充分阐明AD病变发生的性别特异性机制.